Novel motif:69: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:53, 9 September 2013
name: | motif69_RYKNAAATC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0097045 | phosphatidylserine exposure on blood platelet | 2.812123e-13 |
GO:0046836 | glycolipid transport | 5.035282e-11 |
GO:0051024 | positive regulation of immunoglobulin secretion | 1.409144e-10 |
GO:0032655 | regulation of interleukin-12 production | 2.621958e-10 |
GO:0007610 | behavior | 3.700626e-10 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 5.214721e-10 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.606504e-9 |
GO:0050820 | positive regulation of coagulation | 3.005781e-9 |
GO:0030194 | positive regulation of blood coagulation | 3.555467e-9 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 3.997379e-9 |
GO:0006954 | inflammatory response | 5.335006e-9 |
GO:0006952 | defense response | 7.725291e-9 |
GO:0022410 | circadian sleep/wake cycle process | 8.452588e-9 |
GO:2000366 | positive regulation of STAT protein import into nucleus | 1.115811e-8 |
GO:0070091 | glucagon secretion | 1.115811e-8 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 1.275347e-8 |
GO:0002384 | hepatic immune response | 1.344987e-8 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 1.476102e-8 |
GO:0045765 | regulation of angiogenesis | 1.668577e-8 |
GO:0042745 | circadian sleep/wake cycle | 1.735736e-8 |
GO:0051240 | positive regulation of multicellular organismal process | 1.757710e-8 |
GO:0001764 | neuron migration | 2.533109e-8 |
GO:0046851 | negative regulation of bone remodeling | 2.954563e-8 |
GO:0042752 | regulation of circadian rhythm | 3.813053e-8 |
GO:0048512 | circadian behavior | 5.085929e-8 |
GO:0007565 | female pregnancy | 6.314746e-8 |
GO:0006959 | humoral immune response | 6.684619e-8 |
GO:0051239 | regulation of multicellular organismal process | 7.932214e-8 |
GO:0051023 | regulation of immunoglobulin secretion | 9.251197e-8 |
GO:0060124 | positive regulation of growth hormone secretion | 9.751988e-8 |
GO:0001781 | neutrophil apoptosis | 9.808942e-8 |
GO:0032695 | negative regulation of interleukin-12 production | 9.836226e-8 |
GO:0002543 | activation of blood coagulation via clotting cascade | 1.050573e-7 |
GO:0006955 | immune response | 1.155558e-7 |
GO:0009408 | response to heat | 1.198794e-7 |
GO:0046850 | regulation of bone remodeling | 1.199731e-7 |
GO:0018065 | protein-cofactor linkage | 1.563636e-7 |
GO:0010757 | negative regulation of plasminogen activation | 1.956321e-7 |
GO:0009597 | detection of virus | 2.155933e-7 |
GO:0010755 | regulation of plasminogen activation | 3.112024e-7 |
GO:0060123 | regulation of growth hormone secretion | 3.440450e-7 |
GO:0034104 | negative regulation of tissue remodeling | 4.116830e-7 |
GO:0051223 | regulation of protein transport | 4.369569e-7 |
GO:0001776 | leukocyte homeostasis | 4.810310e-7 |
GO:0032101 | regulation of response to external stimulus | 4.842653e-7 |
GO:0043066 | negative regulation of apoptosis | 5.224726e-7 |
GO:0051382 | kinetochore assembly | 5.422679e-7 |
GO:0060548 | negative regulation of cell death | 5.564309e-7 |
GO:2000026 | regulation of multicellular organismal development | 5.678368e-7 |
GO:0061041 | regulation of wound healing | 5.766075e-7 |
GO:0071034 | CUT catabolic process | 6.221180e-7 |
GO:0070489 | T cell aggregation | 6.221180e-7 |
GO:0045727 | positive regulation of translation | 7.062163e-7 |
GO:0014074 | response to purine-containing compound | 7.485428e-7 |
GO:0050818 | regulation of coagulation | 7.518890e-7 |
GO:0031000 | response to caffeine | 7.588771e-7 |
GO:0032755 | positive regulation of interleukin-6 production | 7.608965e-7 |
GO:0050709 | negative regulation of protein secretion | 7.639537e-7 |
GO:0032494 | response to peptidoglycan | 7.762132e-7 |
GO:0045779 | negative regulation of bone resorption | 8.219959e-7 |
GO:0007622 | rhythmic behavior | 8.219959e-7 |
GO:0043069 | negative regulation of programmed cell death | 8.290621e-7 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 9.503591e-7 |
GO:0010722 | regulation of ferrochelatase activity | 9.580940e-7 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 9.589726e-7 |
GO:0051383 | kinetochore organization | 1.307087e-6 |
GO:0051704 | multi-organism process | 1.322694e-6 |
GO:0007619 | courtship behavior | 1.375981e-6 |
GO:0045321 | leukocyte activation | 1.407093e-6 |
GO:0071347 | cellular response to interleukin-1 | 1.427442e-6 |
GO:0001780 | neutrophil homeostasis | 1.458841e-6 |
GO:0045124 | regulation of bone resorption | 1.645007e-6 |
GO:0034508 | centromere complex assembly | 1.663094e-6 |
GO:0032675 | regulation of interleukin-6 production | 1.718553e-6 |
GO:0001819 | positive regulation of cytokine production | 1.774973e-6 |
GO:0002260 | lymphocyte homeostasis | 1.812019e-6 |
GO:0070555 | response to interleukin-1 | 1.832543e-6 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.932274e-6 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 2.030715e-6 |
GO:0070102 | interleukin-6-mediated signaling pathway | 2.075160e-6 |
GO:0030193 | regulation of blood coagulation | 2.280707e-6 |
GO:0007566 | embryo implantation | 2.364092e-6 |
GO:0032680 | regulation of tumor necrosis factor production | 2.781678e-6 |
GO:0000236 | mitotic prometaphase | 2.879057e-6 |
GO:0009595 | detection of biotic stimulus | 2.975408e-6 |
GO:0035520 | monoubiquitinated protein deubiquitination | 3.064073e-6 |
GO:0070201 | regulation of establishment of protein localization | 3.202798e-6 |
GO:0002694 | regulation of leukocyte activation | 3.555108e-6 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 3.645812e-6 |
GO:0071593 | lymphocyte aggregation | 3.856059e-6 |
GO:0000165 | MAPKKK cascade | 3.982353e-6 |
GO:0007252 | I-kappaB phosphorylation | 4.162175e-6 |
GO:0050865 | regulation of cell activation | 4.260412e-6 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 4.271990e-6 |
GO:0046649 | lymphocyte activation | 4.537452e-6 |
GO:0051249 | regulation of lymphocyte activation | 4.649411e-6 |
GO:0032386 | regulation of intracellular transport | 4.824546e-6 |
GO:0002684 | positive regulation of immune system process | 5.382560e-6 |
GO:0035690 | cellular response to drug | 5.494659e-6 |
GO:0048520 | positive regulation of behavior | 5.899357e-6 |
GO:0035556 | intracellular signal transduction | 6.199605e-6 |
GO:0051241 | negative regulation of multicellular organismal process | 6.736662e-6 |
GO:0051971 | positive regulation of transmission of nerve impulse | 6.808885e-6 |
GO:0002262 | myeloid cell homeostasis | 6.941336e-6 |
GO:0048305 | immunoglobulin secretion | 7.393072e-6 |
GO:0043502 | regulation of muscle adaptation | 7.596359e-6 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 7.606531e-6 |
GO:0046822 | regulation of nucleocytoplasmic transport | 7.753712e-6 |
GO:0051701 | interaction with host | 8.049967e-6 |
GO:0070375 | BMK cascade | 8.084862e-6 |
GO:0010466 | negative regulation of peptidase activity | 8.139283e-6 |
GO:0071354 | cellular response to interleukin-6 | 8.384777e-6 |
GO:0006916 | anti-apoptosis | 8.454358e-6 |
GO:0001817 | regulation of cytokine production | 8.553827e-6 |
GO:0071675 | regulation of mononuclear cell migration | 8.620983e-6 |
GO:0046545 | development of primary female sexual characteristics | 8.895327e-6 |
GO:0035093 | spermatogenesis, exchange of chromosomal proteins | 9.083457e-6 |
GO:0001782 | B cell homeostasis | 9.281239e-6 |
GO:0032388 | positive regulation of intracellular transport | 1.000012e-5 |
GO:0048511 | rhythmic process | 1.037429e-5 |
GO:0002376 | immune system process | 1.065757e-5 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.106646e-5 |
GO:0046651 | lymphocyte proliferation | 1.112904e-5 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 1.150797e-5 |
GO:0043652 | engulfment of apoptotic cell | 1.150797e-5 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 1.150797e-5 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 1.150797e-5 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.150797e-5 |
GO:0002548 | monocyte chemotaxis | 1.178864e-5 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.187183e-5 |
GO:0034123 | positive regulation of toll-like receptor signaling pathway | 1.247919e-5 |
GO:0032880 | regulation of protein localization | 1.274843e-5 |
GO:0031296 | B cell costimulation | 1.324952e-5 |
GO:0042307 | positive regulation of protein import into nucleus | 1.329263e-5 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 1.358757e-5 |
GO:0010955 | negative regulation of protein processing | 1.454433e-5 |
GO:0055117 | regulation of cardiac muscle contraction | 1.499456e-5 |
GO:0042035 | regulation of cytokine biosynthetic process | 1.516459e-5 |
GO:0046716 | muscle cell homeostasis | 1.521619e-5 |
GO:0019941 | modification-dependent protein catabolic process | 1.666617e-5 |
GO:0002687 | positive regulation of leukocyte migration | 1.703989e-5 |
GO:0052548 | regulation of endopeptidase activity | 1.795144e-5 |
GO:0030595 | leukocyte chemotaxis | 1.815446e-5 |
GO:0002685 | regulation of leukocyte migration | 1.880536e-5 |
GO:0031646 | positive regulation of neurological system process | 1.948234e-5 |
GO:0050877 | neurological system process | 1.985079e-5 |
GO:0050710 | negative regulation of cytokine secretion | 2.016505e-5 |
GO:0042110 | T cell activation | 2.033594e-5 |
GO:0051094 | positive regulation of developmental process | 2.081599e-5 |
GO:0010759 | positive regulation of macrophage chemotaxis | 2.133936e-5 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 2.152357e-5 |
GO:0006915 | apoptosis | 2.180654e-5 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 2.513340e-5 |
GO:0043170 | macromolecule metabolic process | 2.558885e-5 |
GO:0009057 | macromolecule catabolic process | 2.583476e-5 |
GO:0097035 | regulation of membrane lipid distribution | 2.689395e-5 |
GO:0032966 | negative regulation of collagen biosynthetic process | 2.855987e-5 |
GO:0006119 | oxidative phosphorylation | 2.913644e-5 |
GO:0043129 | surfactant homeostasis | 2.968552e-5 |
GO:0043154 | negative regulation of caspase activity | 2.973828e-5 |
GO:0070661 | leukocyte proliferation | 2.976755e-5 |
GO:0031349 | positive regulation of defense response | 3.016809e-5 |
GO:0016525 | negative regulation of angiogenesis | 3.031077e-5 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 3.095446e-5 |
GO:0014739 | positive regulation of muscle hyperplasia | 3.159498e-5 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.174572e-5 |
GO:0000296 | spermine transport | 3.175681e-5 |
GO:0002218 | activation of innate immune response | 3.281056e-5 |
GO:0033157 | regulation of intracellular protein transport | 3.304446e-5 |
GO:0048518 | positive regulation of biological process | 3.313405e-5 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 3.344089e-5 |
GO:0048685 | negative regulation of collateral sprouting of intact axon in response to injury | 3.450804e-5 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 3.468418e-5 |
GO:0043201 | response to leucine | 3.476888e-5 |
GO:0006540 | glutamate decarboxylation to succinate | 3.487444e-5 |
GO:0010758 | regulation of macrophage chemotaxis | 3.487789e-5 |
GO:0045073 | regulation of chemokine biosynthetic process | 3.554610e-5 |
GO:0045137 | development of primary sexual characteristics | 3.564930e-5 |
GO:0050795 | regulation of behavior | 3.586527e-5 |
GO:0046660 | female sex differentiation | 3.893339e-5 |
GO:0010647 | positive regulation of cell communication | 3.990118e-5 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 4.073454e-5 |
GO:0032103 | positive regulation of response to external stimulus | 4.088970e-5 |
GO:0007009 | plasma membrane organization | 4.148344e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 4.174758e-5 |
GO:0023056 | positive regulation of signaling | 4.240159e-5 |
GO:0046834 | lipid phosphorylation | 4.269896e-5 |
GO:0030334 | regulation of cell migration | 4.351547e-5 |
GO:0002252 | immune effector process | 4.379018e-5 |
GO:0044265 | cellular macromolecule catabolic process | 4.397167e-5 |
GO:0032943 | mononuclear cell proliferation | 4.485019e-5 |
GO:0051932 | synaptic transmission, GABAergic | 4.560850e-5 |
GO:0051093 | negative regulation of developmental process | 4.712026e-5 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 4.720209e-5 |
GO:0002675 | positive regulation of acute inflammatory response | 4.874689e-5 |
GO:0042306 | regulation of protein import into nucleus | 4.903544e-5 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 4.999589e-5 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 5.009104e-5 |
GO:0010468 | regulation of gene expression | 5.053236e-5 |
GO:0048584 | positive regulation of response to stimulus | 5.059477e-5 |
GO:0046854 | phosphatidylinositol phosphorylation | 5.184370e-5 |
GO:0009065 | glutamine family amino acid catabolic process | 5.343625e-5 |
GO:0009611 | response to wounding | 5.354440e-5 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 5.383775e-5 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 5.383775e-5 |
GO:0007371 | ventral midline determination | 5.383775e-5 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 5.383775e-5 |
GO:0010574 | regulation of vascular endothelial growth factor production | 5.417950e-5 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 5.510787e-5 |
GO:0050884 | neuromuscular process controlling posture | 5.769828e-5 |
GO:0010766 | negative regulation of sodium ion transport | 5.769828e-5 |
GO:0060255 | regulation of macromolecule metabolic process | 5.865664e-5 |
GO:0033689 | negative regulation of osteoblast proliferation | 5.878483e-5 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 6.138585e-5 |
GO:0007270 | neuron-neuron synaptic transmission | 6.213780e-5 |
GO:0034764 | positive regulation of transmembrane transport | 6.321506e-5 |
GO:0090316 | positive regulation of intracellular protein transport | 6.334452e-5 |
GO:2000191 | regulation of fatty acid transport | 6.352660e-5 |
GO:0048634 | regulation of muscle organ development | 6.465645e-5 |
GO:0021795 | cerebral cortex cell migration | 6.510341e-5 |
GO:0012501 | programmed cell death | 6.668125e-5 |
GO:0007623 | circadian rhythm | 6.889305e-5 |
GO:0016049 | cell growth | 6.922347e-5 |
GO:0048732 | gland development | 6.926775e-5 |
GO:0044257 | cellular protein catabolic process | 7.060173e-5 |
GO:0002634 | regulation of germinal center formation | 7.383434e-5 |
GO:0008585 | female gonad development | 7.432995e-5 |
GO:0046903 | secretion | 7.444744e-5 |
GO:0030163 | protein catabolic process | 7.461304e-5 |
GO:0009266 | response to temperature stimulus | 7.585227e-5 |
GO:0060326 | cell chemotaxis | 8.017103e-5 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 8.434644e-5 |
GO:0048522 | positive regulation of cellular process | 8.592198e-5 |
GO:0019222 | regulation of metabolic process | 8.739281e-5 |
GO:0006911 | phagocytosis, engulfment | 8.792345e-5 |
GO:0032845 | negative regulation of homeostatic process | 8.939932e-5 |
GO:0070995 | NADPH oxidation | 9.069722e-5 |
GO:0019230 | proprioception | 9.069722e-5 |
GO:0010941 | regulation of cell death | 9.089884e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 9.107045e-5 |
GO:0060249 | anatomical structure homeostasis | 9.184821e-5 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.302391e-5 |
GO:0031326 | regulation of cellular biosynthetic process | 9.303534e-5 |
GO:0042113 | B cell activation | 9.607149e-5 |
GO:0071504 | cellular response to heparin | 9.640378e-5 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 9.666126e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 1.001726e-4 |
GO:0050793 | regulation of developmental process | 1.005039e-4 |
GO:0051346 | negative regulation of hydrolase activity | 1.016512e-4 |
GO:0009581 | detection of external stimulus | 1.041869e-4 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 1.052538e-4 |
GO:0080090 | regulation of primary metabolic process | 1.054214e-4 |
GO:0008406 | gonad development | 1.055847e-4 |
GO:0051224 | negative regulation of protein transport | 1.069837e-4 |
GO:0051180 | vitamin transport | 1.072319e-4 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 1.092283e-4 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.106091e-4 |
GO:0001561 | fatty acid alpha-oxidation | 1.107782e-4 |
GO:0046184 | aldehyde biosynthetic process | 1.120853e-4 |
GO:0090331 | negative regulation of platelet aggregation | 1.128721e-4 |
GO:0061110 | dense core granule biogenesis | 1.128721e-4 |
GO:0042628 | mating plug formation | 1.128721e-4 |
GO:0061108 | seminal vesicle epithelium development | 1.128721e-4 |
GO:0042493 | response to drug | 1.150398e-4 |
GO:0046883 | regulation of hormone secretion | 1.159504e-4 |
GO:0045667 | regulation of osteoblast differentiation | 1.173628e-4 |
GO:0050708 | regulation of protein secretion | 1.202882e-4 |
GO:0061039 | ovum-producing ovary development | 1.206230e-4 |
GO:0046620 | regulation of organ growth | 1.212611e-4 |
GO:0070613 | regulation of protein processing | 1.273634e-4 |
GO:0046485 | ether lipid metabolic process | 1.281264e-4 |
GO:0046618 | drug export | 1.288441e-4 |
GO:0009889 | regulation of biosynthetic process | 1.312605e-4 |
GO:0009617 | response to bacterium | 1.339312e-4 |
GO:0010038 | response to metal ion | 1.359592e-4 |
GO:0016226 | iron-sulfur cluster assembly | 1.366966e-4 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1.368155e-4 |
GO:0031323 | regulation of cellular metabolic process | 1.371390e-4 |
GO:0022602 | ovulation cycle process | 1.391570e-4 |
GO:0060284 | regulation of cell development | 1.394261e-4 |
GO:0009607 | response to biotic stimulus | 1.396381e-4 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 1.397144e-4 |
GO:0010713 | negative regulation of collagen metabolic process | 1.398987e-4 |
GO:0002253 | activation of immune response | 1.409825e-4 |
GO:0046546 | development of primary male sexual characteristics | 1.435250e-4 |
GO:0002251 | organ or tissue specific immune response | 1.458566e-4 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.468431e-4 |
GO:0006417 | regulation of translation | 1.477614e-4 |
GO:0034205 | beta-amyloid formation | 1.494190e-4 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 1.496990e-4 |
GO:0052572 | response to host immune response | 1.531295e-4 |
GO:0051349 | positive regulation of lyase activity | 1.535834e-4 |
GO:0007113 | endomitotic cell cycle | 1.540400e-4 |
GO:0048148 | behavioral response to cocaine | 1.561549e-4 |
GO:0045597 | positive regulation of cell differentiation | 1.577526e-4 |
GO:0071503 | response to heparin | 1.607982e-4 |
GO:0050890 | cognition | 1.654035e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.692195e-4 |
GO:0051222 | positive regulation of protein transport | 1.705781e-4 |
GO:0010033 | response to organic substance | 1.709347e-4 |
GO:0060341 | regulation of cellular localization | 1.720856e-4 |
GO:0051607 | defense response to virus | 1.738152e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.753699e-4 |
GO:0042221 | response to chemical stimulus | 1.847821e-4 |
GO:0050867 | positive regulation of cell activation | 1.861585e-4 |
GO:0034103 | regulation of tissue remodeling | 1.868585e-4 |
GO:0009886 | post-embryonic morphogenesis | 1.909981e-4 |
GO:0009891 | positive regulation of biosynthetic process | 1.914774e-4 |
GO:0050778 | positive regulation of immune response | 1.915449e-4 |
GO:0072678 | T cell migration | 1.919546e-4 |
GO:0070536 | protein K63-linked deubiquitination | 1.978790e-4 |
GO:0044260 | cellular macromolecule metabolic process | 1.991204e-4 |
GO:0009056 | catabolic process | 2.010538e-4 |
GO:0052547 | regulation of peptidase activity | 2.019566e-4 |
GO:0032308 | positive regulation of prostaglandin secretion | 2.030931e-4 |
GO:0070925 | organelle assembly | 2.034744e-4 |
GO:0002696 | positive regulation of leukocyte activation | 2.079871e-4 |
GO:0032026 | response to magnesium ion | 2.081388e-4 |
GO:0003127 | detection of nodal flow | 2.086525e-4 |
GO:0045721 | negative regulation of gluconeogenesis | 2.170738e-4 |
GO:0019228 | regulation of action potential in neuron | 2.174264e-4 |
GO:0032735 | positive regulation of interleukin-12 production | 2.190420e-4 |
GO:0042698 | ovulation cycle | 2.219831e-4 |
GO:0002682 | regulation of immune system process | 2.247764e-4 |
GO:0008584 | male gonad development | 2.274306e-4 |
GO:0002221 | pattern recognition receptor signaling pathway | 2.313303e-4 |
GO:0008283 | cell proliferation | 2.316941e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 2.326641e-4 |
GO:0042908 | xenobiotic transport | 2.349474e-4 |
GO:0043331 | response to dsRNA | 2.369412e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 2.369779e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.400917e-4 |
GO:0002446 | neutrophil mediated immunity | 2.441195e-4 |
GO:0002832 | negative regulation of response to biotic stimulus | 2.481752e-4 |
GO:0010763 | positive regulation of fibroblast migration | 2.581317e-4 |
GO:0045089 | positive regulation of innate immune response | 2.603159e-4 |
GO:0051716 | cellular response to stimulus | 2.632949e-4 |
GO:0035249 | synaptic transmission, glutamatergic | 2.659506e-4 |
GO:0042981 | regulation of apoptosis | 2.676790e-4 |
GO:0006499 | N-terminal protein myristoylation | 2.688318e-4 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 2.707864e-4 |
GO:0051252 | regulation of RNA metabolic process | 2.733369e-4 |
GO:0045884 | regulation of survival gene product expression | 2.766650e-4 |
GO:0002237 | response to molecule of bacterial origin | 2.801864e-4 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 2.803396e-4 |
GO:0043277 | apoptotic cell clearance | 2.823653e-4 |
GO:0019087 | transformation of host cell by virus | 2.824894e-4 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 2.842747e-4 |
GO:0046685 | response to arsenic-containing substance | 2.868164e-4 |
GO:0051960 | regulation of nervous system development | 2.898481e-4 |
GO:0043067 | regulation of programmed cell death | 2.912568e-4 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 2.921013e-4 |
GO:0002521 | leukocyte differentiation | 2.934476e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 3.006259e-4 |
GO:0051918 | negative regulation of fibrinolysis | 3.065295e-4 |
GO:0071243 | cellular response to arsenic-containing substance | 3.086724e-4 |
GO:0008050 | female courtship behavior | 3.180665e-4 |
GO:0032496 | response to lipopolysaccharide | 3.187570e-4 |
GO:0009249 | protein lipoylation | 3.252488e-4 |
GO:0002700 | regulation of production of molecular mediator of immune response | 3.293113e-4 |
GO:0030259 | lipid glycosylation | 3.302799e-4 |
GO:0006554 | lysine catabolic process | 3.417411e-4 |
GO:0008049 | male courtship behavior | 3.428301e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 3.430757e-4 |
GO:0000085 | G2 phase of mitotic cell cycle | 3.445066e-4 |
GO:0016075 | rRNA catabolic process | 3.537497e-4 |
GO:0051592 | response to calcium ion | 3.540031e-4 |
GO:0016567 | protein ubiquitination | 3.599201e-4 |
GO:0050707 | regulation of cytokine secretion | 3.662948e-4 |
GO:0006235 | dTTP biosynthetic process | 3.670757e-4 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 3.674093e-4 |
GO:0050482 | arachidonic acid secretion | 3.705011e-4 |
GO:0031328 | positive regulation of cellular biosynthetic process | 3.773282e-4 |
GO:0016579 | protein deubiquitination | 3.774192e-4 |
GO:0034346 | positive regulation of type III interferon production | 3.807405e-4 |
GO:0042440 | pigment metabolic process | 3.821126e-4 |
GO:0072592 | oxygen metabolic process | 3.894106e-4 |
GO:0022414 | reproductive process | 3.901309e-4 |
GO:0030098 | lymphocyte differentiation | 3.988261e-4 |
GO:0032663 | regulation of interleukin-2 production | 4.146586e-4 |
GO:0051707 | response to other organism | 4.163536e-4 |
GO:0021547 | midbrain-hindbrain boundary initiation | 4.170488e-4 |
GO:0021501 | prechordal plate formation | 4.170488e-4 |
GO:0000003 | reproduction | 4.188191e-4 |
GO:0045059 | positive thymic T cell selection | 4.312559e-4 |
GO:0051282 | regulation of sequestering of calcium ion | 4.320461e-4 |
GO:0050921 | positive regulation of chemotaxis | 4.333453e-4 |
GO:2000145 | regulation of cell motility | 4.390239e-4 |
GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 4.454329e-4 |
GO:0034698 | response to gonadotropin stimulus | 4.645672e-4 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 4.665817e-4 |
GO:0071333 | cellular response to glucose stimulus | 4.679792e-4 |
GO:0051353 | positive regulation of oxidoreductase activity | 4.680113e-4 |
GO:0048807 | female genitalia morphogenesis | 4.706767e-4 |
GO:0007611 | learning or memory | 4.740474e-4 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 4.769147e-4 |
GO:0021905 | forebrain-midbrain boundary formation | 4.769147e-4 |
GO:0003322 | pancreatic A cell development | 4.769147e-4 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 4.769147e-4 |
GO:0051209 | release of sequestered calcium ion into cytosol | 4.778102e-4 |
GO:0002637 | regulation of immunoglobulin production | 4.800794e-4 |
GO:0008152 | metabolic process | 4.811522e-4 |
GO:0007243 | intracellular protein kinase cascade | 4.859349e-4 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 5.005622e-4 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 5.012345e-4 |
GO:0040014 | regulation of multicellular organism growth | 5.051127e-4 |
GO:0035239 | tube morphogenesis | 5.115214e-4 |
GO:0071636 | positive regulation of transforming growth factor beta production | 5.215707e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 5.351920e-4 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 5.353007e-4 |
GO:0022618 | ribonucleoprotein complex assembly | 5.363296e-4 |
GO:0048583 | regulation of response to stimulus | 5.413202e-4 |
GO:0034633 | retinol transport | 5.422405e-4 |
GO:0001834 | trophectodermal cell proliferation | 5.422405e-4 |
GO:0002758 | innate immune response-activating signal transduction | 5.437261e-4 |
GO:0045732 | positive regulation of protein catabolic process | 5.458545e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 5.476375e-4 |
GO:0032474 | otolith morphogenesis | 5.679927e-4 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 5.699760e-4 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 5.706583e-4 |
GO:0030970 | retrograde protein transport, ER to cytosol | 5.706583e-4 |
GO:0043368 | positive T cell selection | 5.731699e-4 |
GO:0032410 | negative regulation of transporter activity | 5.871727e-4 |
GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep | 5.921426e-4 |
GO:0006355 | regulation of transcription, DNA-dependent | 6.055003e-4 |
GO:0014741 | negative regulation of muscle hypertrophy | 6.100093e-4 |
GO:0030278 | regulation of ossification | 6.141184e-4 |
GO:0051047 | positive regulation of secretion | 6.159860e-4 |
GO:0043217 | myelin maintenance | 6.163009e-4 |
GO:0046661 | male sex differentiation | 6.288217e-4 |
GO:0033555 | multicellular organismal response to stress | 6.312996e-4 |
GO:0046888 | negative regulation of hormone secretion | 6.435794e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 6.457686e-4 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 6.688733e-4 |
GO:0007165 | signal transduction | 6.766075e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6.818313e-4 |
GO:0031644 | regulation of neurological system process | 6.829033e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 6.843857e-4 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 6.868261e-4 |
GO:0002683 | negative regulation of immune system process | 6.879399e-4 |
GO:0043279 | response to alkaloid | 6.912373e-4 |
GO:0045087 | innate immune response | 6.916986e-4 |
GO:0002286 | T cell activation involved in immune response | 6.998522e-4 |
GO:0016265 | death | 7.093512e-4 |
GO:0051917 | regulation of fibrinolysis | 7.224898e-4 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.227841e-4 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 7.434195e-4 |
GO:0051969 | regulation of transmission of nerve impulse | 7.638343e-4 |
GO:0007059 | chromosome segregation | 7.642944e-4 |
GO:0002544 | chronic inflammatory response | 7.648266e-4 |
GO:0010596 | negative regulation of endothelial cell migration | 7.681582e-4 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 7.686977e-4 |
GO:0051310 | metaphase plate congression | 7.767829e-4 |
GO:0048513 | organ development | 7.826201e-4 |
GO:0040012 | regulation of locomotion | 7.883591e-4 |
GO:0040040 | thermosensory behavior | 8.034444e-4 |
GO:0034112 | positive regulation of homotypic cell-cell adhesion | 8.034444e-4 |
GO:0014743 | regulation of muscle hypertrophy | 8.055308e-4 |
GO:0042391 | regulation of membrane potential | 8.095744e-4 |
GO:0030217 | T cell differentiation | 8.123022e-4 |
GO:0048265 | response to pain | 8.130383e-4 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 8.207795e-4 |
GO:0071715 | icosanoid transport | 8.255512e-4 |
GO:0009967 | positive regulation of signal transduction | 8.467899e-4 |
GO:0007589 | body fluid secretion | 8.473492e-4 |
GO:0010467 | gene expression | 8.780333e-4 |
GO:0019242 | methylglyoxal biosynthetic process | 8.812610e-4 |
GO:0030162 | regulation of proteolysis | 8.816094e-4 |
GO:0060152 | microtubule-based peroxisome localization | 8.898041e-4 |
GO:0048608 | reproductive structure development | 8.952982e-4 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 9.011854e-4 |
GO:0060157 | urinary bladder development | 9.060154e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 9.152004e-4 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 9.235524e-4 |
GO:0042100 | B cell proliferation | 9.416537e-4 |
GO:0071216 | cellular response to biotic stimulus | 9.422258e-4 |
GO:0032446 | protein modification by small protein conjugation | 9.475053e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 9.600738e-4 |
GO:0048243 | norepinephrine secretion | 9.643104e-4 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 9.711231e-4 |
GO:0007548 | sex differentiation | 9.776196e-4 |
GO:0008219 | cell death | 9.806289e-4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 9.841109e-4 |
GO:0050830 | defense response to Gram-positive bacterium | 9.849733e-4 |
GO:0051895 | negative regulation of focal adhesion assembly | 9.862955e-4 |
GO:0050920 | regulation of chemotaxis | 9.866788e-4 |
GO:0051051 | negative regulation of transport | 1.006715e-3 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.018065e-3 |
GO:0030258 | lipid modification | 1.021339e-3 |
GO:0006950 | response to stress | 1.029465e-3 |
GO:0019098 | reproductive behavior | 1.036285e-3 |
GO:0046148 | pigment biosynthetic process | 1.049561e-3 |
GO:0050790 | regulation of catalytic activity | 1.075614e-3 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 1.078047e-3 |
GO:0031342 | negative regulation of cell killing | 1.083299e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.084755e-3 |
GO:0035092 | sperm chromatin condensation | 1.086763e-3 |
GO:0016477 | cell migration | 1.099976e-3 |
GO:0046677 | response to antibiotic | 1.102734e-3 |
GO:0046208 | spermine catabolic process | 1.103913e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048240 | sperm capacitation | 5.015268e-25 |
GO:0006400 | tRNA modification | 3.835618e-20 |
GO:0030488 | tRNA methylation | 9.494742e-20 |
GO:0001510 | RNA methylation | 1.359064e-13 |
GO:0008033 | tRNA processing | 2.411205e-13 |
GO:0009451 | RNA modification | 4.534992e-12 |
GO:0048515 | spermatid differentiation | 7.289033e-12 |
GO:0007286 | spermatid development | 3.544791e-10 |
GO:0055119 | relaxation of cardiac muscle | 7.934263e-9 |
GO:0034470 | ncRNA processing | 1.332099e-8 |
GO:0046709 | IDP catabolic process | 1.418331e-8 |
GO:0046032 | ADP catabolic process | 1.418331e-8 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 2.144375e-8 |
GO:0006581 | acetylcholine catabolic process | 2.246230e-8 |
GO:0014904 | myotube cell development | 5.294943e-8 |
GO:0006399 | tRNA metabolic process | 5.557829e-8 |
GO:0007271 | synaptic transmission, cholinergic | 8.685295e-8 |
GO:0060282 | positive regulation of oocyte development | 8.795969e-8 |
GO:0060281 | regulation of oocyte development | 8.795969e-8 |
GO:0050819 | negative regulation of coagulation | 9.036183e-8 |
GO:0009566 | fertilization | 1.057591e-7 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.595589e-7 |
GO:0043931 | ossification involved in bone maturation | 1.595589e-7 |
GO:0008291 | acetylcholine metabolic process | 1.679309e-7 |
GO:0048469 | cell maturation | 1.721911e-7 |
GO:0006835 | dicarboxylic acid transport | 1.966137e-7 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.404472e-7 |
GO:0021700 | developmental maturation | 2.649516e-7 |
GO:0018105 | peptidyl-serine phosphorylation | 3.225081e-7 |
GO:0030195 | negative regulation of blood coagulation | 3.378707e-7 |
GO:0070977 | bone maturation | 4.763933e-7 |
GO:0002676 | regulation of chronic inflammatory response | 4.946818e-7 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 7.827508e-7 |
GO:0002678 | positive regulation of chronic inflammatory response | 8.450942e-7 |
GO:0060741 | prostate gland stromal morphogenesis | 8.716785e-7 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.171275e-6 |
GO:0035630 | bone mineralization involved in bone maturation | 1.171275e-6 |
GO:0032878 | regulation of establishment or maintenance of cell polarity | 1.386940e-6 |
GO:0043129 | surfactant homeostasis | 1.489489e-6 |
GO:0048610 | cellular process involved in reproduction | 2.301386e-6 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 2.361219e-6 |
GO:0070375 | BMK cascade | 3.682042e-6 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase cascade | 3.856833e-6 |
GO:0010823 | negative regulation of mitochondrion organization | 3.913853e-6 |
GO:0070723 | response to cholesterol | 5.148207e-6 |
GO:0060736 | prostate gland growth | 6.050519e-6 |
GO:0006214 | thymidine catabolic process | 6.068797e-6 |
GO:0045213 | neurotransmitter receptor metabolic process | 6.949493e-6 |
GO:0040014 | regulation of multicellular organism growth | 7.463128e-6 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 7.640850e-6 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 8.337190e-6 |
GO:0046326 | positive regulation of glucose import | 8.506410e-6 |
GO:0051932 | synaptic transmission, GABAergic | 8.695283e-6 |
GO:0051224 | negative regulation of protein transport | 8.949058e-6 |
GO:0015939 | pantothenate metabolic process | 9.036237e-6 |
GO:0010656 | negative regulation of muscle cell apoptosis | 9.546081e-6 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.016802e-5 |
GO:0010564 | regulation of cell cycle process | 1.017716e-5 |
GO:0000492 | box C/D snoRNP assembly | 1.028007e-5 |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1.060519e-5 |
GO:0051726 | regulation of cell cycle | 1.070949e-5 |
GO:0060740 | prostate gland epithelium morphogenesis | 1.081161e-5 |
GO:0003207 | cardiac chamber formation | 1.198370e-5 |
GO:0060512 | prostate gland morphogenesis | 1.284451e-5 |
GO:0043069 | negative regulation of programmed cell death | 1.288573e-5 |
GO:0001974 | blood vessel remodeling | 1.309993e-5 |
GO:0048145 | regulation of fibroblast proliferation | 1.345703e-5 |
GO:0003211 | cardiac ventricle formation | 1.618812e-5 |
GO:0006212 | uracil catabolic process | 1.665248e-5 |
GO:0060548 | negative regulation of cell death | 1.762693e-5 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.981925e-5 |
GO:0046826 | negative regulation of protein export from nucleus | 2.047517e-5 |
GO:0031119 | tRNA pseudouridine synthesis | 2.300973e-5 |
GO:0046069 | cGMP catabolic process | 2.387855e-5 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 2.626753e-5 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 2.630976e-5 |
GO:0031397 | negative regulation of protein ubiquitination | 2.731225e-5 |
GO:0046373 | L-arabinose metabolic process | 3.152888e-5 |
GO:0042311 | vasodilation | 3.374824e-5 |
GO:0035234 | germ cell programmed cell death | 3.387891e-5 |
GO:0001780 | neutrophil homeostasis | 3.404221e-5 |
GO:0006071 | glycerol metabolic process | 3.432385e-5 |
GO:0034660 | ncRNA metabolic process | 3.517815e-5 |
GO:0007281 | germ cell development | 3.519054e-5 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 3.661776e-5 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 3.871119e-5 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 3.911787e-5 |
GO:0046031 | ADP metabolic process | 4.044479e-5 |
GO:0009446 | putrescine biosynthetic process | 4.158841e-5 |
GO:0006493 | protein O-linked glycosylation | 4.291235e-5 |
GO:0043066 | negative regulation of apoptosis | 4.476635e-5 |
GO:0060509 | Type I pneumocyte differentiation | 4.508324e-5 |
GO:0051450 | myoblast proliferation | 4.513886e-5 |
GO:0010828 | positive regulation of glucose transport | 4.612396e-5 |
GO:0032101 | regulation of response to external stimulus | 4.950792e-5 |
GO:0014743 | regulation of muscle hypertrophy | 5.135586e-5 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 5.262775e-5 |
GO:0006507 | GPI anchor release | 5.262775e-5 |
GO:0031348 | negative regulation of defense response | 5.464484e-5 |
GO:0002320 | lymphoid progenitor cell differentiation | 5.611983e-5 |
GO:0003215 | cardiac right ventricle morphogenesis | 6.409915e-5 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 6.584702e-5 |
GO:0002328 | pro-B cell differentiation | 6.677716e-5 |
GO:0031570 | DNA integrity checkpoint | 6.762963e-5 |
GO:0000077 | DNA damage checkpoint | 6.785044e-5 |
GO:2000241 | regulation of reproductive process | 6.818051e-5 |
GO:0060749 | mammary gland alveolus development | 7.113167e-5 |
GO:0006222 | UMP biosynthetic process | 7.285500e-5 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 8.287447e-5 |
GO:0010941 | regulation of cell death | 8.297844e-5 |
GO:0008216 | spermidine metabolic process | 8.366705e-5 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 8.978102e-5 |
GO:0045786 | negative regulation of cell cycle | 9.117304e-5 |
GO:0060525 | prostate glandular acinus development | 9.686412e-5 |
GO:0014066 | regulation of phosphatidylinositol 3-kinase cascade | 1.030814e-4 |
GO:0071156 | regulation of cell cycle arrest | 1.079558e-4 |
GO:0060442 | branching involved in prostate gland morphogenesis | 1.085067e-4 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 1.096591e-4 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.113698e-4 |
GO:0006210 | thymine catabolic process | 1.147860e-4 |
GO:0019400 | alditol metabolic process | 1.210307e-4 |
GO:0014911 | positive regulation of smooth muscle cell migration | 1.220721e-4 |
GO:0019695 | choline metabolic process | 1.235576e-4 |
GO:0018209 | peptidyl-serine modification | 1.238814e-4 |
GO:0015826 | threonine transport | 1.276992e-4 |
GO:0034589 | hydroxyproline transport | 1.276992e-4 |
GO:0043067 | regulation of programmed cell death | 1.287093e-4 |
GO:0001662 | behavioral fear response | 1.298396e-4 |
GO:0043501 | skeletal muscle adaptation | 1.307397e-4 |
GO:0043620 | regulation of DNA-dependent transcription in response to stress | 1.309540e-4 |
GO:0061138 | morphogenesis of a branching epithelium | 1.358657e-4 |
GO:0042596 | fear response | 1.398032e-4 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 1.411701e-4 |
GO:0048844 | artery morphogenesis | 1.433824e-4 |
GO:0002209 | behavioral defense response | 1.469448e-4 |
GO:0090317 | negative regulation of intracellular protein transport | 1.538266e-4 |
GO:0042135 | neurotransmitter catabolic process | 1.560288e-4 |
GO:0046425 | regulation of JAK-STAT cascade | 1.727987e-4 |
GO:0043503 | skeletal muscle fiber adaptation | 1.798563e-4 |
GO:0032060 | bleb assembly | 1.798563e-4 |
GO:0045839 | negative regulation of mitosis | 1.847232e-4 |
GO:0010660 | regulation of muscle cell apoptosis | 1.865648e-4 |
GO:0035909 | aorta morphogenesis | 1.865648e-4 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 1.882702e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 1.893534e-4 |
GO:0001763 | morphogenesis of a branching structure | 1.935156e-4 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 2.070138e-4 |
GO:0030850 | prostate gland development | 2.111494e-4 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 2.116269e-4 |
GO:0097116 | gephyrin clustering | 2.153892e-4 |
GO:0009452 | RNA capping | 2.161873e-4 |
GO:0071425 | hemopoietic stem cell proliferation | 2.186060e-4 |
GO:0030879 | mammary gland development | 2.354811e-4 |
GO:0003006 | developmental process involved in reproduction | 2.382099e-4 |
GO:0015711 | organic anion transport | 2.385660e-4 |
GO:0071397 | cellular response to cholesterol | 2.387884e-4 |
GO:0007614 | short-term memory | 2.435005e-4 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 2.463627e-4 |
GO:0035910 | ascending aorta morphogenesis | 2.463627e-4 |
GO:0002244 | hemopoietic progenitor cell differentiation | 2.499840e-4 |
GO:0010948 | negative regulation of cell cycle process | 2.684096e-4 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 2.707409e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 2.707409e-4 |
GO:0048814 | regulation of dendrite morphogenesis | 2.720171e-4 |
GO:0006974 | response to DNA damage stimulus | 2.793758e-4 |
GO:0022616 | DNA strand elongation | 2.801711e-4 |
GO:0045821 | positive regulation of glycolysis | 2.810642e-4 |
GO:0032102 | negative regulation of response to external stimulus | 2.868137e-4 |
GO:0042981 | regulation of apoptosis | 2.882511e-4 |
GO:0007263 | nitric oxide mediated signal transduction | 2.932641e-4 |
GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 3.074930e-4 |
GO:0032801 | receptor catabolic process | 3.198507e-4 |
GO:0060134 | prepulse inhibition | 3.269250e-4 |
GO:0010544 | negative regulation of platelet activation | 3.643407e-4 |
GO:0000075 | cell cycle checkpoint | 3.684149e-4 |
GO:0060563 | neuroepithelial cell differentiation | 4.055658e-4 |
GO:0032868 | response to insulin stimulus | 4.490695e-4 |
GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 4.545088e-4 |
GO:0042402 | cellular biogenic amine catabolic process | 4.556831e-4 |
GO:0008016 | regulation of heart contraction | 4.587850e-4 |
GO:0019089 | transmission of virus | 4.703335e-4 |
GO:0044111 | development involved in symbiotic interaction | 4.703335e-4 |
GO:0015825 | L-serine transport | 4.703335e-4 |
GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 4.703335e-4 |
GO:0070201 | regulation of establishment of protein localization | 4.783636e-4 |
GO:0014888 | striated muscle adaptation | 4.906946e-4 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 4.941171e-4 |
GO:0042350 | GDP-L-fucose biosynthetic process | 5.120793e-4 |
GO:0015811 | L-cystine transport | 5.120793e-4 |
GO:0033136 | serine phosphorylation of STAT3 protein | 5.120793e-4 |
GO:0003183 | mitral valve morphogenesis | 5.141585e-4 |
GO:0014896 | muscle hypertrophy | 5.371854e-4 |
GO:0003230 | cardiac atrium development | 5.384664e-4 |
GO:0048754 | branching morphogenesis of a tube | 5.390660e-4 |
GO:0042501 | serine phosphorylation of STAT protein | 5.794117e-4 |
GO:0090273 | regulation of somatostatin secretion | 5.893023e-4 |
GO:0046121 | deoxyribonucleoside catabolic process | 5.978456e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.978456e-4 |
GO:2000425 | regulation of apoptotic cell clearance | 6.092247e-4 |
GO:0021801 | cerebral cortex radial glia guided migration | 6.133119e-4 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 6.133119e-4 |
GO:0010466 | negative regulation of peptidase activity | 6.360580e-4 |
GO:0031400 | negative regulation of protein modification process | 6.624833e-4 |
GO:0006396 | RNA processing | 6.742890e-4 |
GO:0034224 | cellular response to zinc ion starvation | 6.840644e-4 |
GO:0019532 | oxalate transport | 6.840644e-4 |
GO:0002683 | negative regulation of immune system process | 7.161319e-4 |
GO:0050765 | negative regulation of phagocytosis | 7.410380e-4 |
GO:0032800 | receptor biosynthetic process | 7.583482e-4 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 7.659662e-4 |
GO:2000243 | positive regulation of reproductive process | 7.704787e-4 |
GO:0090075 | relaxation of muscle | 7.763532e-4 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 7.863604e-4 |
GO:0051223 | regulation of protein transport | 7.934531e-4 |
GO:2000826 | regulation of heart morphogenesis | 8.033711e-4 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 8.080868e-4 |
GO:0031342 | negative regulation of cell killing | 8.157594e-4 |
GO:0006370 | mRNA capping | 8.499707e-4 |
GO:0048478 | replication fork protection | 8.782590e-4 |
GO:0014057 | positive regulation of acetylcholine secretion | 8.782590e-4 |
GO:0060840 | artery development | 8.806480e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 8.860523e-4 |
GO:0003283 | atrial septum development | 8.965932e-4 |
GO:0003357 | noradrenergic neuron differentiation | 9.130938e-4 |
GO:0050818 | regulation of coagulation | 9.802669e-4 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 9.841971e-4 |
GO:0001541 | ovarian follicle development | 9.854379e-4 |
GO:0006916 | anti-apoptosis | 9.995532e-4 |
GO:0022612 | gland morphogenesis | 9.996357e-4 |
GO:0071695 | anatomical structure maturation | 1.008757e-3 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.029568e-3 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.032096e-3 |
GO:0097118 | neuroligin clustering | 1.044227e-3 |
GO:0009896 | positive regulation of catabolic process | 1.050849e-3 |
GO:0019227 | neuronal action potential propagation | 1.051675e-3 |
GO:0035108 | limb morphogenesis | 1.078527e-3 |
GO:0048485 | sympathetic nervous system development | 1.092018e-3 |
GO:0050679 | positive regulation of epithelial cell proliferation | 1.117697e-3 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.144131e-3 |
GO:0001887 | selenium compound metabolic process | 1.150701e-3 |
GO:0043526 | neuroprotection | 1.155124e-3 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 1.161420e-3 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 1.161420e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.176489e-3 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 1.218092e-3 |
GO:0022610 | biological adhesion | 1.227645e-3 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 1.243613e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 1.243613e-3 |
GO:0035883 | enteroendocrine cell differentiation | 1.243613e-3 |
GO:0043403 | skeletal muscle tissue regeneration | 1.269457e-3 |
GO:0072329 | monocarboxylic acid catabolic process | 1.276911e-3 |
GO:0002698 | negative regulation of immune effector process | 1.282729e-3 |
GO:0007155 | cell adhesion | 1.296161e-3 |
GO:0007399 | nervous system development | 1.327044e-3 |
GO:0050728 | negative regulation of inflammatory response | 1.337994e-3 |
GO:0000723 | telomere maintenance | 1.349661e-3 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 1.354669e-3 |
GO:0060039 | pericardium development | 1.355961e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.359061e-3 |
GO:0051054 | positive regulation of DNA metabolic process | 1.367674e-3 |
GO:0051262 | protein tetramerization | 1.380735e-3 |
GO:0042770 | signal transduction in response to DNA damage | 1.386413e-3 |
GO:0008295 | spermidine biosynthetic process | 1.400810e-3 |
GO:0003209 | cardiac atrium morphogenesis | 1.420220e-3 |
GO:0030193 | regulation of blood coagulation | 1.425492e-3 |
GO:0007405 | neuroblast proliferation | 1.425892e-3 |
GO:0031018 | endocrine pancreas development | 1.451320e-3 |
GO:0031860 | telomeric 3' overhang formation | 1.474027e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.474027e-3 |
GO:0001971 | negative regulation of activation of membrane attack complex | 1.474027e-3 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 1.474548e-3 |
GO:0046777 | protein autophosphorylation | 1.480443e-3 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.480538e-3 |
GO:0015908 | fatty acid transport | 1.561814e-3 |
GO:0061041 | regulation of wound healing | 1.600174e-3 |
GO:0035904 | aorta development | 1.618467e-3 |
GO:0046579 | positive regulation of Ras protein signal transduction | 1.618467e-3 |
GO:0043112 | receptor metabolic process | 1.658755e-3 |
GO:0018343 | protein farnesylation | 1.683339e-3 |
GO:0043500 | muscle adaptation | 1.684406e-3 |
GO:0010867 | positive regulation of triglyceride biosynthetic process | 1.691097e-3 |
GO:0032329 | serine transport | 1.699752e-3 |
GO:0019673 | GDP-mannose metabolic process | 1.699752e-3 |
GO:0015808 | L-alanine transport | 1.699752e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.715447e-3 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.723145e-3 |
GO:0071773 | cellular response to BMP stimulus | 1.796653e-3 |
GO:0002076 | osteoblast development | 1.801093e-3 |
GO:0019233 | sensory perception of pain | 1.819103e-3 |
GO:0019395 | fatty acid oxidation | 1.825993e-3 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 1.851719e-3 |
GO:0051899 | membrane depolarization | 1.871501e-3 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.885026e-3 |
GO:0006622 | protein targeting to lysosome | 1.891286e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.019357e-3 |
GO:0015718 | monocarboxylic acid transport | 2.031916e-3 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 2.041119e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 2.041353e-3 |
GO:0021795 | cerebral cortex cell migration | 2.049500e-3 |
GO:0060041 | retina development in camera-type eye | 2.078200e-3 |
GO:0046427 | positive regulation of JAK-STAT cascade | 2.081977e-3 |
GO:0080134 | regulation of response to stress | 2.104092e-3 |
GO:0045740 | positive regulation of DNA replication | 2.122424e-3 |
GO:0042119 | neutrophil activation | 2.127339e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 2.189071e-3 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 2.217902e-3 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 2.219543e-3 |
GO:0042769 | DNA damage response, detection of DNA damage | 2.219543e-3 |
GO:0035881 | amacrine cell differentiation | 2.227153e-3 |
GO:0031508 | centromeric heterochromatin formation | 2.227153e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 2.297595e-3 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 2.306122e-3 |
GO:0060011 | Sertoli cell proliferation | 2.306122e-3 |
GO:0006596 | polyamine biosynthetic process | 2.306122e-3 |
GO:0061308 | cardiac neural crest cell development involved in heart development | 2.352145e-3 |
GO:0060737 | prostate gland morphogenetic growth | 2.352145e-3 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.356660e-3 |
GO:0006004 | fucose metabolic process | 2.357862e-3 |
GO:0061029 | eyelid development in camera-type eye | 2.403732e-3 |
GO:0006090 | pyruvate metabolic process | 2.406927e-3 |
GO:0060536 | cartilage morphogenesis | 2.422893e-3 |
GO:0032094 | response to food | 2.508415e-3 |
GO:0032880 | regulation of protein localization | 2.537728e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.595937e-3 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 2.609090e-3 |
GO:0045683 | negative regulation of epidermis development | 2.632216e-3 |
GO:0050880 | regulation of blood vessel size | 2.654291e-3 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 2.673019e-3 |
GO:0032200 | telomere organization | 2.695242e-3 |
GO:0008585 | female gonad development | 2.695459e-3 |
GO:0051346 | negative regulation of hydrolase activity | 2.733061e-3 |
GO:0035150 | regulation of tube size | 2.737857e-3 |
GO:0010766 | negative regulation of sodium ion transport | 2.742184e-3 |
GO:0009062 | fatty acid catabolic process | 2.757448e-3 |
GO:0060174 | limb bud formation | 2.804671e-3 |
GO:0051451 | myoblast migration | 2.819669e-3 |
GO:0031347 | regulation of defense response | 2.820562e-3 |
GO:0032147 | activation of protein kinase activity | 2.826615e-3 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 2.828649e-3 |
GO:0071403 | cellular response to high density lipoprotein particle stimulus | 2.828696e-3 |
GO:0071448 | cellular response to alkyl hydroperoxide | 2.828696e-3 |
GO:0071315 | cellular response to morphine | 2.828696e-3 |
GO:0031269 | pseudopodium assembly | 2.828696e-3 |
GO:0071307 | cellular response to vitamin K | 2.828696e-3 |
GO:0010430 | fatty acid omega-oxidation | 2.828696e-3 |
GO:0050904 | diapedesis | 2.828696e-3 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 2.871137e-3 |
GO:0060973 | cell migration involved in heart development | 2.913435e-3 |
GO:0060413 | atrial septum morphogenesis | 2.924880e-3 |
GO:0090187 | positive regulation of pancreatic juice secretion | 2.949662e-3 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 2.949662e-3 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 2.949662e-3 |
GO:0070827 | chromatin maintenance | 2.949662e-3 |
GO:0035945 | mitochondrial ncRNA surveillance | 2.949662e-3 |
GO:0035946 | mitochondrial mRNA surveillance | 2.949662e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 2.949662e-3 |
GO:0031623 | receptor internalization | 2.951414e-3 |
GO:0002009 | morphogenesis of an epithelium | 2.959163e-3 |
GO:0001766 | membrane raft polarization | 3.024812e-3 |
GO:0022602 | ovulation cycle process | 3.027453e-3 |
GO:0051893 | regulation of focal adhesion assembly | 3.057906e-3 |
GO:0048286 | lung alveolus development | 3.083891e-3 |
GO:0060279 | positive regulation of ovulation | 3.083924e-3 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 3.210993e-3 |
GO:0031340 | positive regulation of vesicle fusion | 3.210993e-3 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 3.228229e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 3.273120e-3 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 3.363477e-3 |
GO:0050866 | negative regulation of cell activation | 3.376823e-3 |
GO:0034720 | histone H3-K4 demethylation | 3.388394e-3 |
GO:0033261 | regulation of S phase | 3.430579e-3 |
GO:0045059 | positive thymic T cell selection | 3.465237e-3 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 3.480294e-3 |
GO:0042760 | very long-chain fatty acid catabolic process | 3.542280e-3 |
GO:0003218 | cardiac left ventricle formation | 3.542280e-3 |
GO:0001547 | antral ovarian follicle growth | 3.584574e-3 |
GO:0060765 | regulation of androgen receptor signaling pathway | 3.602357e-3 |
GO:0003179 | heart valve morphogenesis | 3.659416e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 3.675591e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.807249e-3 |
GO:0051239 | regulation of multicellular organismal process | 3.810494e-3 |
GO:0007283 | spermatogenesis | 3.813638e-3 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 3.932083e-3 |
GO:0021799 | cerebral cortex radially oriented cell migration | 3.932083e-3 |
GO:2000351 | regulation of endothelial cell apoptosis | 3.943886e-3 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 3.961586e-3 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 3.961586e-3 |
GO:0032943 | mononuclear cell proliferation | 4.004728e-3 |
GO:0046651 | lymphocyte proliferation | 4.066998e-3 |
GO:0060019 | radial glial cell differentiation | 4.122168e-3 |
GO:0060173 | limb development | 4.155996e-3 |
GO:0051665 | membrane raft localization | 4.182396e-3 |
GO:0034440 | lipid oxidation | 4.241487e-3 |
GO:0048483 | autonomic nervous system development | 4.268155e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 4.279197e-3 |
GO:0051051 | negative regulation of transport | 4.357500e-3 |
GO:0008283 | cell proliferation | 4.399511e-3 |
GO:0006595 | polyamine metabolic process | 4.434654e-3 |
GO:0051930 | regulation of sensory perception of pain | 4.451365e-3 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 4.524807e-3 |
GO:0003289 | atrial septum primum morphogenesis | 4.585455e-3 |
GO:0050727 | regulation of inflammatory response | 4.589363e-3 |
GO:0045830 | positive regulation of isotype switching | 4.606205e-3 |
GO:0051799 | negative regulation of hair follicle development | 4.615563e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 4.616878e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 4.616878e-3 |
GO:0003326 | pancreatic A cell fate commitment | 4.616878e-3 |
GO:0048745 | smooth muscle tissue development | 4.708262e-3 |
GO:0055107 | Golgi to secretory granule transport | 4.750378e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 4.750378e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 4.750378e-3 |
GO:0030328 | prenylcysteine catabolic process | 4.750378e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 4.750378e-3 |
GO:0030324 | lung development | 4.752502e-3 |
GO:0060068 | vagina development | 4.785289e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 4.894215e-3 |
GO:0032494 | response to peptidoglycan | 4.956852e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 4.974805e-3 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 4.991153e-3 |
GO:0021575 | hindbrain morphogenesis | 5.072790e-3 |
GO:0051100 | negative regulation of binding | 5.093516e-3 |
GO:0042701 | progesterone secretion | 5.237789e-3 |
GO:0035524 | proline transmembrane transport | 5.237789e-3 |
GO:0046324 | regulation of glucose import | 5.335774e-3 |
GO:0071391 | cellular response to estrogen stimulus | 5.347009e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 5.384416e-3 |
GO:0001707 | mesoderm formation | 5.398549e-3 |
GO:0006108 | malate metabolic process | 5.435840e-3 |
GO:0006275 | regulation of DNA replication | 5.462586e-3 |
GO:0060541 | respiratory system development | 5.480687e-3 |
GO:0048747 | muscle fiber development | 5.539435e-3 |
GO:0003170 | heart valve development | 5.586286e-3 |
GO:0090045 | positive regulation of deacetylase activity | 5.605561e-3 |
GO:0003151 | outflow tract morphogenesis | 5.610941e-3 |
GO:0070661 | leukocyte proliferation | 5.615409e-3 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 5.640997e-3 |
GO:0006820 | anion transport | 5.676639e-3 |
GO:0007346 | regulation of mitotic cell cycle | 5.696613e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 5.702219e-3 |
GO:0019751 | polyol metabolic process | 5.745922e-3 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 5.825243e-3 |
GO:0021623 | oculomotor nerve formation | 5.825243e-3 |
GO:0003409 | optic cup structural organization | 5.825243e-3 |
GO:0005989 | lactose biosynthetic process | 5.825243e-3 |
GO:0003404 | optic vesicle morphogenesis | 5.825243e-3 |
GO:0008285 | negative regulation of cell proliferation | 5.836228e-3 |
GO:0003219 | cardiac right ventricle formation | 5.847278e-3 |
GO:0032870 | cellular response to hormone stimulus | 5.961612e-3 |
GO:0046633 | alpha-beta T cell proliferation | 5.998468e-3 |
GO:0060523 | prostate epithelial cord elongation | 6.096610e-3 |
GO:0021557 | oculomotor nerve development | 6.096610e-3 |
GO:0032025 | response to cobalt ion | 6.096610e-3 |
GO:0032328 | alanine transport | 6.125290e-3 |
GO:0060426 | lung vasculature development | 6.133379e-3 |
GO:0006893 | Golgi to plasma membrane transport | 6.133379e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 6.192248e-3 |
GO:0030323 | respiratory tube development | 6.226896e-3 |
GO:0040018 | positive regulation of multicellular organism growth | 6.262182e-3 |
GO:0045445 | myoblast differentiation | 6.276071e-3 |
GO:0043923 | positive regulation by host of viral transcription | 6.350364e-3 |
GO:0035019 | somatic stem cell maintenance | 6.356676e-3 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 6.424815e-3 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 6.426257e-3 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 6.532489e-3 |
GO:0021563 | glossopharyngeal nerve development | 6.605392e-3 |
GO:0031952 | regulation of protein autophosphorylation | 6.732588e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 6.769432e-3 |
GO:0071281 | cellular response to iron ion | 6.845432e-3 |
GO:0051057 | positive regulation of small GTPase mediated signal transduction | 6.877712e-3 |
GO:0006145 | purine base catabolic process | 7.012129e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 7.013827e-3 |
GO:0010165 | response to X-ray | 7.104917e-3 |
GO:0001654 | eye development | 7.116469e-3 |
GO:0043010 | camera-type eye development | 7.122600e-3 |
GO:0043922 | negative regulation by host of viral transcription | 7.258858e-3 |
GO:0048333 | mesodermal cell differentiation | 7.275250e-3 |
GO:0010756 | positive regulation of plasminogen activation | 7.294669e-3 |
GO:0042921 | glucocorticoid receptor signaling pathway | 7.314795e-3 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 7.314795e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 7.318533e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 7.318533e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 7.318533e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 7.318533e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 7.318533e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 7.318533e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 7.318533e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 7.318533e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 7.318533e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 7.318533e-3 |
GO:0010543 | regulation of platelet activation | 7.585244e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 7.668706e-3 |
GO:0060463 | lung lobe morphogenesis | 7.727514e-3 |
GO:0050678 | regulation of epithelial cell proliferation | 7.743083e-3 |
GO:0008284 | positive regulation of cell proliferation | 7.787478e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 7.836610e-3 |
GO:0034341 | response to interferon-gamma | 7.862112e-3 |
GO:0042698 | ovulation cycle | 7.874503e-3 |
GO:0032897 | negative regulation of viral transcription | 7.961138e-3 |
GO:0045916 | negative regulation of complement activation | 7.990620e-3 |
GO:0003018 | vascular process in circulatory system | 8.008372e-3 |